EU lists rare nerve disorder as side effect of J&J Covid-19 vaccineEuropean Medicines Agency (EMA), Guillain-Barré Syndrome, Johnson & Johnson, Nerve Disease, Pharmacovigilance Risk Assessment Committee (PRAC), Rare Diseases, Side EffectsEurope’s medicines regulator added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson’s Covid-19 vaccine after the European Medicines Agency reviewed 108 cases reported worldwide. Read more July 22, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/02/Bahrain-first-to-approve-Johnson-Johnson-COVID-19-vaccine-for-emergency-use-regulator-Reuters-2-25-21.jpeg 226 370 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-07-22 10:18:532021-07-22 13:03:10EU lists rare nerve disorder as side effect of J&J Covid-19 vaccine